Bloomberg
Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal
Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.
View original source — Bloomberg ↗
Related stories
The Punch
BusinessAug 28, 2026 · 1 min
Lagos NIPR expands LAPRIGA award categories
The Punch
The Punch
BusinessAug 28, 2026 · 1 min
CBN cuts T-bill rate amid N3.63tn demand
The Punch
CNBC
BusinessAug 28, 2026 · 1 min
Iran links Hormuz reopening to ending regional wars as Trump reportedly rejects return to June deal
CNBC
The Punch
BusinessAug 28, 2026 · 1 min
Nigeria’s external reserves hit $53.11bn, near 2009 record
The Punch